International
The Morning Science

What science found today

‹
 

Research

Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA

Medical Xpress ·

Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA

The Brief

  • A commonly used drug, azacitidine, has been a major treatment for high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) for more than two decades.
  • The drug was long thought to work through DNA by stripping off chemical tags that keep genes silenced.
  • A new report says azacitidine kills leukemia cells early mainly by acting on RNA rather than DNA.

Why it matters

Identifying RNA rather than DNA as the main target of a widely used leukemia drug changes how its mechanism is understood, which could inform future treatment design.

Who’s affected

  • researchers in leukemia and blood cancers
  • clinicians and patients who use azacitidine for MDS and AML

For more than two decades, azacitidine has been a major treatment for blood cancers such as high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The drug was thought to work through DNA, by stripping off the chemical tags that keep genes silenced and…

How do you feel about this?

0 Comments

    Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA – The Morning Science